Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Topicsgeriatric

Phys · geriatric

Parkinson's Disease in Older Adults

Also known as Parkinson's Disease in Older Adults · parkinson's disease in older adults · Parkinson's disease · idiopathic Parkinson's disease · PD · paralysis agitans · levodopa-induced dyskinesia · Parkinson's disease psychosis

Consultant-physician depth guide to Parkinson's disease in older adults for FRACP DWE/DCE preparation — MDS clinical diagnostic criteria, levodopa pharmacology and motor complications (wearing-off, dyskinesia, on–off fluctuations), device-assisted therapies (apomorphine, levodopa–carbidopa intestinal gel, foslevodopa–foscarbidopa subcutaneous infusion, deep brain stimulation), non-motor symptoms (cognitive decline, psychosis, autonomic failure, falls, freezing of gait), pimavanserin for Parkinson's disease psychosis, palliative care at end of life, and adjustments for frailty, multimorbidity and polypharmacy. Structured for FRACP DWE/DCE, MRCP and ABIM preparation.

high12 referencesUpdated 26 July 202610 min readVerification in progress

Practise this topic

  • 10 MCQs
  • SAQ
  • Viva
  • Case

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Acute marked deterioration in a stable Parkinson's patient — think intercurrent infection (urinary, respiratory), medication omission (especially in a nil-by-mouth admission), or drug-induced (antipsychotic, antiemetic, GI prokinetic); not disease progression
  • Parkinson's disease psychosis — visual hallucinations, paranoid delusions and agitation — predicts nursing-home placement and doubles mortality; treat with pimavanserin (or low-dose clozapine, quetiapine) and avoid first-generation antipsychotics which worsen parkinsonism
  • Sudden severe freezing or gait ignition failure with postural instability in a previously mobile patient — consider normal-pressure hydrocephalus, cervical myelopathy, or transition to atypical parkinsonism (progressive supranuclear palsy, multiple system atrophy)
  • Aspiration pneumonia — the leading cause of death in advanced Parkinson's; assess swallowing, modify fluid consistency, refer to speech pathology
  • Neuroleptic malignant syndrome or parkinsonism–hyperpyrexia syndrome from abrupt levodopa withdrawal — fever, rigidity, rhabdomyolysis, delirium; reinstate dopaminergic therapy immediately and cool the patient
  • Orthostatic hypotension from autonomic failure worsened by levodopa and dopaminergic agents — falls, syncope, cognitive fluctuation; reduce culprit drugs and add midodrine or fludrocortisone
On this page
Study tools

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Acute marked deterioration in a stable Parkinson's patient — think intercurrent infection (urinary, respiratory), medication omission (especially in a nil-by-mouth admission), or drug-induced (antipsychotic, antiemetic, GI prokinetic); not disease progression
  • Parkinson's disease psychosis — visual hallucinations, paranoid delusions and agitation — predicts nursing-home placement and doubles mortality; treat with pimavanserin (or low-dose clozapine, quetiapine) and avoid first-generation antipsychotics which worsen parkinsonism
  • Sudden severe freezing or gait ignition failure with postural instability in a previously mobile patient — consider normal-pressure hydrocephalus, cervical myelopathy, or transition to atypical parkinsonism (progressive supranuclear palsy, multiple system atrophy)
  • Aspiration pneumonia — the leading cause of death in advanced Parkinson's; assess swallowing, modify fluid consistency, refer to speech pathology
  • Neuroleptic malignant syndrome or parkinsonism–hyperpyrexia syndrome from abrupt levodopa withdrawal — fever, rigidity, rhabdomyolysis, delirium; reinstate dopaminergic therapy immediately and cool the patient
  • Orthostatic hypotension from autonomic failure worsened by levodopa and dopaminergic agents — falls, syncope, cognitive fluctuation; reduce culprit drugs and add midodrine or fludrocortisone
The one-line answer

Parkinson's disease is a synucleinopathy defined by the MDS clinical diagnostic criteria — bradykinesia plus rest tremor or rigidity, with supportive features and no absolute exclusion criteria. Management is staged: confirm the diagnosis and exclude mimics, start levodopa when symptoms impair function, escalate refractory motor fluctuations to device-assisted therapy, and manage non-motor symptoms proactively. The cardinal rule that every junior breaks is never block dopamine — no metoclopramide, no haloperidol — and the leading cause of death is aspiration pneumonia.[1][2]

Meet the patient

Mrs Y is a 78-year-old with eight years of akinetic-rigid Parkinson's disease. She is admitted with aspiration pneumonia, her usual levodopa has been withheld because she is nil by mouth, and she is now stiffer, febrile, and confused. The registrar has written metoclopramide for the nausea. The questions that decide her survival are whether you reinstate the levodopa safely, swap the antiemetic before it worsens her parkinsonism, and assess the swallowing that caused the aspiration in the first place.[2][4]

Hold those three levers — never omit levodopa, never block dopamine, find the precipitant — and the whole topic falls into place.[2]

Physician Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References12ShowHide
  1. [1]Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord, 2015.PMID 26474316
  2. [2]Armstrong MJ, Okun MS Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 2020.PMID 32044947
  3. [3]Okun MS Deep-brain stimulation for Parkinson's disease. N Engl J Med, 2012.PMID 23075179
  4. [4]Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet, 2014.PMID 24183563
  5. [5]Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol, 2017.PMID 28257128
  6. [6]Goldman JG, Sieg E Cognitive Impairment and Dementia in Parkinson Disease. Clin Geriatr Med, 2020.PMID 32222308
  7. [7]Pahwa R, Lyons KE Levodopa-related wearing-off in Parkinson's disease: identification and management. Curr Med Res Opin, 2009.PMID 19228103
  8. [8]Kwok JYY, Smith R, Chan LML, et al. Managing freezing of gait in Parkinson's disease: a systematic review and network meta-analysis. J Neurol, 2022.PMID 35244766
  9. [9]Mouchaileh N, Cameron J Device-assisted therapies for Parkinson disease. Aust Prescr, 2025.PMID 40040736
  10. [10]Walker RW Palliative care and end-of-life planning in Parkinson's disease. J Neural Transm (Vienna), 2013.PMID 23328948
  11. [11]Akbar U, McQueen RB, Bemski J, et al. Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review. J Neurol Neurosurg Psychiatry, 2021.PMID 33789923
  12. [12]Blair HA Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease. CNS Drugs, 2025.PMID 40198538

Test yourself

Practise what you just read

  • 10 MCQs
  • SAQ
  • Viva
  • Case
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousOrthogeriatrics and Perioperative Medicine in Older AdultsgeriatricNextPolypharmacy and Deprescribinggeriatric